Akèy › Osteyosakòm › Texas › Dallas
Etid klinik pou Osteyosakòm nan Dallas, TX
5 etid pou Osteyosakòm ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Ap rekriteFaz 2
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Ap rekriteFaz 1/2
- Children's Medical Center, Dallas
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Ap rekriteFaz 1/2
- Children's Medical Center, Dallas
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Ap rekriteFaz 3
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Ap rekriteEtid obsèvasyon
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Etid Osteyosakòm nan lòt vil
- Memphis, TN10 etid
- St. Louis, MO10 etid
- Atlanta, GA10 etid
- Boston, MA9 etid
- Mountain View, CA8 etid
- Chicago, IL7 etid
- Birmingham, AL7 etid
- Houston, TX7 etid
- Los Angeles, CA7 etid
- Tampa, FL6 etid
- Washington, DC6 etid
- New York City, NY6 etid
Lòt etid nan Dallas
- Kansè nan tete54 etid
- Kansè Poumon ki pa ti selil52 etid
- Ensifizyans kadyak42 etid
- Kansè Metastatik42 etid
- Kansè (tout kalite)38 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite31 etid
- Kansè ovè28 etid
- Kansè vejik27 etid
- Kansè poumon27 etid
- Kansè Endomèt25 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.